Literature DB >> 1285125

U1 snRNP targets an essential splicing factor, U2AF65, to the 3' splice site by a network of interactions spanning the exon.

B E Hoffman1, P J Grabowski.   

Abstract

A description of cellular factors that govern alternative splicing of pre-mRNA is largely incomplete. In the case of the rat preprotachykinin gene, splicing of the alternative exon E4 occurs by a poorly understood mechanism in which exon selection is under the positive control of U1 snRNP. Because the binding of U1 snRNP to the 5' splice site of E4 is coincident with the selection of the 3' splice site of E4, this mechanism would appear to involve interactions that bridge across the exon. In this work, a UV cross-linking strategy was used to identify possible RNA-protein interactions involved in the proposed exon-bridging model. Of particular interest is a prominent 61-kD protein, p61, that binds to the 3' splice site of E4 in a manner that is clearly facilitated by a downstream 5' splice site and U1 snRNP particles. The identity of p61 is the essential splicing factor U2AF65, on the basis of copurification and selective binding to polypyrimidine tracts. These results indicate a model in which exon selection is positively regulated by the communication of U1 snRNP and U2AF65. That is, a natural deficiency in binding U2AF65 to the 3' splice site that leads to exon skipping might be overcome by a mechanism in which U1 snRNP facilitates the binding of U2AF65 through a network of template-directed and exon-bridging interactions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1285125     DOI: 10.1101/gad.6.12b.2554

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  102 in total

1.  Requirements for mini-exon inclusion in potato invertase mRNAs provides evidence for exon-scanning interactions in plants.

Authors:  C G Simpson; P E Hedley; J A Watters; G P Clark; C McQuade; G C Machray; J W Brown
Journal:  RNA       Date:  2000-03       Impact factor: 4.942

2.  Prespliceosomal assembly on microinjected precursor mRNA takes place in nuclear speckles.

Authors:  I Melcák; S Melcáková; V Kopský; J Vecerová; I Raska
Journal:  Mol Biol Cell       Date:  2001-02       Impact factor: 4.138

3.  Functional selection of splicing enhancers that stimulate trans-splicing in vitro.

Authors:  L A Boukis; J P Bruzik
Journal:  RNA       Date:  2001-06       Impact factor: 4.942

4.  Functions of SR proteins in the U12-dependent AT-AC pre-mRNA splicing pathway.

Authors:  M L Hastings; A R Krainer
Journal:  RNA       Date:  2001-03       Impact factor: 4.942

5.  Temperature-dependent splicing of beta-globin pre-mRNA.

Authors:  Federica Gemignani; Peter Sazani; Paul Morcos; Ryszard Kole
Journal:  Nucleic Acids Res       Date:  2002-11-01       Impact factor: 16.971

6.  Excessive RNA splicing and inhibition of HIV-1 replication induced by modified U1 small nuclear RNAs.

Authors:  Dibyakanti Mandal; Zehua Feng; C Martin Stoltzfus
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

7.  The RNA-binding protein TIA-1 is a novel mammalian splicing regulator acting through intron sequences adjacent to a 5' splice site.

Authors:  F Del Gatto-Konczak; C F Bourgeois; C Le Guiner; L Kister; M C Gesnel; J Stévenin; R Breathnach
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

8.  A branch point consensus from Arabidopsis found by non-circular analysis allows for better prediction of acceptor sites.

Authors:  N Tolstrup; P Rouzé; S Brunak
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

9.  Multiple interdependent sequence elements control splicing of a fibroblast growth factor receptor 2 alternative exon.

Authors:  F Del Gatto; A Plet; M C Gesnel; C Fort; R Breathnach
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

10.  Evidence for splice site pairing via intron definition in Schizosaccharomyces pombe.

Authors:  C M Romfo; C J Alvarez; W J van Heeckeren; C J Webb; J A Wise
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.